Showing results (171-180 of 186) with videos related to
Sort By:
Pageof 19
International Journal of Surgery (London, England)|July 18, 2023
Utilization, surgical populations, centers, coverages, regional balance, and their influential factors of deep brain stimulation for Parkinson's disease: a large-scale multicenter cross-sectional study from 1997 to 2021Fangang Meng, Wei Hu, Shu Wang, et al.The Lancet Regional Health. Western Pacific|October 2, 2025
Characteristics and outcomes in atorvastatin therapy for chronic subdural hematoma: a national, observational real-world study in China, 2019-2024Tao Liu, Zhihao Zhao, Jiao Wang, et al.BMC Medical Genomics|July 26, 2015
Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage responseYogesh Kumar, Jianfeng Yang, Taobo Hu, et al.Neuro-Oncology Advances|December 11, 2024
The impact of timing of temozolomide chemoradiotherapy for newly diagnosed glioblastoma on patient overall survival: A multicenter retrospective studyArthur C K Lau, Brandon L H Chan, Carly S K Yeung, et al.Trials|November 20, 2015
Effect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trialRongcai Jiang, Dong Wang, Wai Sang Poon, et al.Journal of Clinical Bioinformatics|January 6, 2015
Copy number variation analysis based on AluScan sequencesJian-Feng Yang, Xiao-Fan Ding, Lei Chen, et al.Journal of Neuro-Oncology|March 11, 2025
Impact of alternating electric fields therapy for newly diagnosed WHO grade 4 astrocytoma on patient survival: a real-world propensity-score adjusted prospective multicenter studyPeter Y M Woo, Jenny K S Pu, Lai-Fung Li, et al.Human Genomics|August 24, 2018
Forward and reverse mutations in stages of cancer developmentTaobo Hu, Yogesh Kumar, Iram Shazia, et al.JAMA Neurology|August 4, 2018
Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized ClinicalTrialRongcai Jiang, Shiguang Zhao, Renzhi Wang, et al.Neuro-Oncology Advances|April 21, 2026
Outcomes of H3K27M-altered diffuse midline glioma adult Chinese patients and real-world experience with German-sourced ONC201 targeted therapy: A multi-center study in Hong KongPeter Y M Woo, Clara K W Lee, Lai-Fung Li, et al.Pageof 19